EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

[Translated article] Multicenter retrospective analysis of sodium thiosulfate as treatment for non-uremic calciphylaxis

Laura Cardona-Roca, Laura Borràs Trias, Rosario Bueno Uceda, Adrià Siles, Adrián Vilariño Seijas, Nuria Rudi Sola, Carlos Seguí-Solanes

Farmacia Hospitalaria · 2025

DOI: 10.1016/j.farma.2025.05.015 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Farmacia Hospitalaria, 2025. Verfasst von Laura Cardona-Roca und 6 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Farmacia, Hospital General de Granollers, Barcelona, Spain. Electronic address: laura.cardona95@gmail.com. Hauptthemen laut MEDLINE: Calciphylaxis, Thiosulfates, Chelating Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To describe the results obtained in terms of effectiveness and safety of intravenous sodium thiosulfate in patients diagnosed with non-uremic calciphylaxis, to identify and analyse possible etiological factors of the disease, and to determine the associated morbidity and mortality. METHOD: A multicenter and retrospective study was conducted with patients diagnosed with non-uremic calciphylaxis who received intravenous sodium thiosulfate between 2013 and 2023. Effectiveness was evaluated based on the status of the ulcers at the end of treatment, and safety was assessed according to the main reported adverse effects and the need for dosage adjustment. RESULTS: A total of 33 patients from three university hospitals were evaluated (93.9% Caucasian, 78.8% women, mean age 80 [SD 8.1] years) with non-uremic calciphylaxis confirmed by skin biopsy. The localization pattern was 90.9% distal. The following complementary therapeutic measures were undertaken: topical wound care, removal of precipitating factors (mainly vitamin D supplements and vitamin K antagonists), medications to reduce calcification (bisphosphonates, cinacalcet), and techniques to promote ulcer healing. The main associated factors for developing calciphylaxis were: non-uremic chronic kidney disease (81.8%), vitamin D supplementation (72.7%), and hypoalbuminemia (66.7%). The most commonly used sodium thiosulfate dosage was 25 g (n = 26) three times per week (n = 28) intravenously, with a median treatment duration of 11.4 (IQR 5.7-18) weeks. A complete resolution or improvement of the ulcers was achieved in 78.8% of the cases. Adverse effects were observed in 96.7% of patients, with the most common being metabolic acidosis (n = 19) and nausea and/or vomiting (n = 18). Dosage adjustments due to toxicity were necessary in 9% of cases. The significant morbidity rate was 69.7% (n = 23). The main complications were: 57.6% ulcer superinfection and 24.3% poor pain control. The overall mortality rate was 66.7%; 42.4% within the first 6 months after diagnosis and 39.4% secondary to non-uremic calciphylaxis. CONCLUSIONS: Sodium thiosulfate shows a potential benefit in the treatment of ulcers due to non-uremic calciphylaxis, with a similar safety profile to that reported for uremic calciphylaxis, considering the high morbidity and mortality associated with the condition. Further studies are needed to determine its efficacy and assess the specific contribution of the different treatments used.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalciphylaxisThiosulfatesChelating AgentsHumansRetrospective StudiesFemaleMaleAged, 80 and overAgedMiddle AgedTreatment Outcome

Stichwörter der Autor:innen

CalcifilaxisCalcifilaxis no urémicaCalciphylaxisEfectividadEffectivenessNonuremic calciphylaxisSafetySeguridadSodium thiosulfateTiosulfato sódicoUlcerÚlcera

Substanzen

sodium thiosulfateThiosulfatesChelating Agents

Autor:innen und Institutionen

  • Servicio de Farmacia, Hospital General de Granollers, Barcelona, Spain. Electronic address: laura.cardona95@gmail.com.
  • Servicio de Farmacia, Hospital General de Granollers, Barcelona, Spain.
  • Servicio de Farmacia, Hospital Parc Taulí, Barcelona, Spain.
  • Servicio de Farmacia, Hospital Germans Trias i Pujol, Barcelona, Spain.

Zitieren

APA

Cardona-Roca, L., Borràs Trias, L., Bueno Uceda, R., Siles, A., Vilariño Seijas, A., Rudi Sola, N., & Seguí-Solanes, C. (2025). [Translated article] Multicenter retrospective analysis of sodium thiosulfate as treatment for non-uremic calciphylaxis. Farmacia Hospitalaria. https://doi.org/10.1016/j.farma.2025.05.015

Vancouver

Cardona-Roca L, Borràs Trias L, Bueno Uceda R, Siles A, Vilariño Seijas A, Rudi Sola N, et al. [Translated article] Multicenter retrospective analysis of sodium thiosulfate as treatment for non-uremic calciphylaxis. Farmacia Hospitalaria. 2025. doi:10.1016/j.farma.2025.05.015

BibTeX
@article{CardonaRoca2025,
  author = {Cardona-Roca, Laura and Borràs Trias, Laura and Bueno Uceda, Rosario and Siles, Adrià and Vilariño Seijas, Adrián and Rudi Sola, Nuria and Seguí-Solanes, Carlos},
  title = {[Translated article] Multicenter retrospective analysis of sodium thiosulfate as treatment for non-uremic calciphylaxis},
  journal = {Farmacia Hospitalaria},
  year = {2025},
  doi = {10.1016/j.farma.2025.05.015}
}
Kostenlos starten →